ReleaseWire

PioneerRx is the official event host for the 2nd annual American Pharmacy Purchasing Alliance (APPA) national convention, PharmaCon Expo.

Market Research Hub (MRH) has recently added a new research publication on in its wide research repository, which is titled as "Batten Disease-Pipeline Review, H1 2018". This research report on batten disease pipeline review delivers exhaustive information on various therapeutics that are being developed for treating Batten disease. It reflects an in-depth analysis which includes drug target, stage of development, route of administration (RoA), molecule type and mechanism of action (MoA). Further, it focuses on descriptive pharmacological action of therapeutics involved in treating batten disease backed up with a comprehensive research along with latest news, past and present developments as well as press releases.

Brandon K. Welch. President of American Pharmacy Purchasing Alliance (APPA), today launched an e-book titled PBM Mafia.

Q BioMed Inc., a biotechnology acceleration company, is pleased to welcome Dr. Rick Panicucci as an independent member on its board of Directors.

ABC Compounding Pharmacy in an Encino pharmacy that has a staff with years of experience creating medical aid for patients. By creating a relationship with their patients they are able to find a positive solution to their medical needs. It is important for ABC Compounding Pharmacy to have patients that feel comfortable and secure in the medicines they are given.

The Sunday Morning Pharmaceuticals group will be launching am Indiegogo campaign for their flagship product, Sunday Mornings Hangover Helper on January 30th. Set to run for 30 days, the campaign seeks to raise $10000 for marketing and ongoing product development, and will allow persons to secure multiple packages of the herbal-based remedy for as little as $19 USD (early bird special), each containing their proprietary powdered mix and two capsules.

This excellent Encino pharmacy goes above and beyond for their patients' well-being and comfort. ABC Compounding Pharmacy is equipped with friendly and caring staff, pharmacists, and technicians who are dedicated to providing top-notch patient care. ABC Compounding Pharmacy is recognized as an exceptional Encino pharmacy that focuses on creating medications specific to patients' needs. Their staff is available to answer any questions a patient may have about compounded medications.

Women who are interested in improving their health through vitamins but aren't sure which supplements are worth taking are encouraged to contact Accutrition Nutritional Consultants today to learn about their Women's Pure Pack currently being offered by Pure Encapsulations. The Women's Pure Pack is a simple and easy way for women over 40 to get the vitamins and nutrients that they need in a once-daily packet that's convenient for business travel or on-the-go lifestyles. Those looking to buy Pure Encapsulation products can visit the Accutrition website.

ABC Compounding Pharmacy is an Encino pharmacy that delivers the best medical aid for patients. Each medication is designed for every patient's individual needs. This pharmacy holds their patients in the highest regard and works tirelessly to give them medications that are suitable for their needs. The Encino pharmacy knows how important patient's needs are; therefore they provide free shipping and delivery to those that are local to the area.

Sernova Corp., a clinical stage company developing regenerative medicine technologies for the long-term treatment of diseases including diabetes and hemophilia, is pleased to announce it has received US Food and Drug Administration (FDA) notice of allowance for its IND for a new human clinical trial with the Cell Pouch System (TM) (CPS) in the United States.

Q BioMed Inc., a biotechnology acceleration company, announced today that Dr. Helen Tager-Flusberg from Boston University has joined its advisory committee for QBM-001, which is being tested for pediatric developmental nonverbal disorder in toddlers within the autism spectrum disorders.

Market Research Hub (MRH) has currently appended a new report on the global Histone Deacetylase 8 - Pipeline Review, H2 2017 in its extensive reports database. The report focuses on Histone Deacetylase 8, which is the enzyme that is encoded in HDAC8 gene. This enzyme denotes significant characteristics in the cell cycle as well as transcriptional regulation development events. The report summarizes the various therapy areas such as Oncology, Renal Cell Carcinoma and T-Cell Leukemia, Central Nervous System, Peripheral T-Cell Lymphomas (PTCL), Gastrointestinal, Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Infectious Disease and Musculoskeletal Disorders, Mantle Cell Lymphoma, Adenoid Cystic Carcinoma (ACC), Melanoma, Marginal Zone B-cell Lymphoma, Breast Cancer, Neurodegenerative Diseases, Colon Cancer, Lung Cancer, Follicular Lymphoma, B-Cell Non-Hodgkin Lymphoma, Pancreatic Cancer, Liver Fibrosis, Bone Disorders, Diffuse Large B-Cell Lymphoma, Colorectal Cancer, Prostate Cancer, Cognitive Disorders , Bladder Cancer, Liver Cancer, Brain Cancer, and Human Immunodeficiency Virus (HIV) Infections (AIDS).

The physicians that own and operate the licensed 420 MD clinics have made the difficult decision to permanently close ALL the 420 MD clinics, and to continue care for existing patients online at 420MDRenewals.com. 420 MD was a pioneer in community based clinics after Prop 215, but a recent proliferation of storefront clinics posing as 420 MD are taking cash and medical information from unsuspecting patients. To protect patient privacy and safety while authorities deal with the impostors, the founding doctor has pulled his license from all the storefronts. 420 MD will no longer see new patients, though previous patients can maintain care and renewals via online telemedicine at 420MDRenewals.com.

Anyone who is having trouble sleeping well is encouraged to check out the benefits associated with a product sold by Accutrition, Kavinace Ultra PM by NeuroScience, and consider whether or not they should buy Kavinace to improve their sleep habits. Kavinace Ultra PM has been found to promote restfulness and better sleep through increased production of serotonin (a precursor to melatonin) and an easing of the symptoms of anxiety that have been known to cause difficulty falling asleep and staying asleep.

ABC Compounding Pharmacy is a premier Encino pharmacy that is dedicated to providing top-notch care to their patients. They believe patients should have full access to compounded medication, which is why they offer free delivery to neighboring cities. Each compounded medication created by the Encino pharmacy is designed to fit a patient's individual needs.

The U.S. Department of Defense may soon be armed with the right to approve drugs and devices that it deems essential to protecting U.S. troops, according to a recent Politico article. To date, the U.S. FDA has been the only government agency with the authority to approve drugs and devices. Section 732 of the National Defense Authorization Act, currently in the Senate, could change this fact. Such a seismic shift in healthcare regulation could have a huge impact on Pluristem Therapeutics' pipeline of cell therapies. Pluristem's PLX-R18 product has shown efficacy in the treatment of Acute Radiation Syndrome (ARS) and is currently being evaluated by both the Department of Defense and National Institutes of Health as a countermeasure for nuclear catastrophes including a potential nuclear attack, a dirty bomb, on a Fukushima-like accident.

Hypertension is the most common risk factor for cardiovascular disease. The condition affects approximately 75 million adults in the United States. Lowering blood pressure to normal levels with appropriate medications reduces cardiac organ damage and prevents bad consequences. Despite the variety of available treatment options, a significant part of the hypertensive population has uncontrolled blood pressure.

According to Fact.MR’s research report on the global peptide based metabolic disorders therapeutics market, the market is anticipated to show a robust growth rate during the forecasted period of 2017-2022 and expected to reflect a value more than US$ 8 Bn.

The North America Sports Medicine & Therapies Market report explores the Top Key Players in-depth analysis as Smith & Nephew plc (UK), DePuy Synthes (US), Medtronics (UK), Zimmer (US), Arthrex, Inc. (US), Stryker Corporation (US), Breg, Inc. (US), CONMED Corporation (US), Tornier N.V. (US), DonJoy, Inc. (US), Mueller Sports, Inc.(US), Ottobock Healthcare GmbH (Germany), DJO Global (US), Cramer, Inc.(US).

Lab managers looking for contract LC method development, column screening, or method troubleshooting/improvement are encouraged to contact YMC America, Inc. By doing so, they can find high-quality services for fee-based LC application and method development. We also specialize in preparative scale-up as well as scaling down methods from HPLC to UHPLC for faster through-put and greater cost savings.

Scientists and lab managers who are searching for the highest quality LC columns, components, and separation materials are encouraged to contact YMC America, Inc.

Intelligence Tree Botanicals, a U.S. based herbal product company announced today, that their patented and well researched herbal supplement NuMemory+ won the coveted Best of Brain Supplement Award from Better Nutrition Magazine.

Finding the right supplements online can be an arduous task, primarily because it's quite difficult to distinguish friend from foe. While some supplements might look alluring and are able to attain one's attention at first glance, they might cause more damage than good in the end, and should thus be avoided.

BlockRx, the first ICO geared to secure the Pharmaceutical industry and incentivize positive patient outcomes, announces internet marketing pioneer Ryan Scott is joining as Executive Advisor.

According to a new series of reports on the U.S. market for immunology drugs by iData Research (www.idataresearch.com), projections show a gradual fall in HUMIRA® market share after 2020 due to the entry of infliximab and etanercept biosimilars, as well as other new drugs. The revenues from HUMIRA® currently account for an estimated 34% of the total U.S. immunology drug market. However, since the patent expiry for HUMIRA® in 2016, there are currently two HUMIRA® biosimilars, namely Amjevita™ and Cyltezo™. However, these drugs are not able to launch due to Humira's strong ancillary patents which will protect them from losing their exclusivity until 2023. These products will cause the average selling price (ASP) of HUMIRA® to decline over the next several years, further deepening the market share erosion caused by biosimilars after 2023.